148 citations
,
March 2022 in “The New England Journal of Medicine” Baricitinib was effective in treating alopecia areata in two major trials.
66 citations
,
June 2021 in “Journal of The American Academy of Dermatology” Baricitinib is effective and safe for treating severe alopecia areata.
17 citations
,
January 2009 in “Nippon Ishinkin Gakkai Zasshi” A 10-year-old boy recovered from a scalp infection caused by a fungus after treatment with itraconazole.
October 2022 in “Amplla Editora eBooks” Traumatic brain injury hospitalizations in Brazil showed specific trends and patterns from 2008 to 2021.
31 citations
,
May 2021 in “Journal of endocrinological investigation” APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.
1 citations
,
August 2021 in “Journal of The American Academy of Dermatology” Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.
1 citations
,
December 2022 in “The Nishinihon Journal of Dermatology” Baricitinib is an effective treatment for severe alopecia areata.
October 2021 in “International Journal of Cosmetic Science”
September 2024 in “BMJ Case Reports” An adult had a rare scalp infection in the forehead area, treated successfully with itraconazole.
November 2023 in “Veterinary Dermatology” 1 citations
,
February 2023 in “Journal of Cosmetic Dermatology” 1 citations
,
July 2021 in “Dermatologic Therapy” 1 citations
,
November 2019 in “Dermatologic Therapy” December 2025 in “Lasers in Surgery and Medicine” February 2025 in “International Journal of Dermatology” February 2025 in “Australasian Journal of Dermatology” October 2022 in “Journal of Cosmetic Dermatology” May 2021 in “FEBS open bio” January 2021 in “Dermatologic Therapy” November 2020 in “Dermatologic Therapy” August 2020 in “International Journal of Dermatology” May 2020 in “Dermatologic Therapy” March 2020 in “Dermatologic Therapy” February 2020 in “Stem Cells Translational Medicine” January 2020 in “Dermatologic Therapy”
October 2018 in “Journal of the European Academy of Dermatology and Venereology” January 2018 in “International Journal of Dermatology” September 2025 in “International Journal of Dermatology”
1 citations
,
June 2022 in “JAMA” Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.
October 2023 in “The Open Dermatology Journal” Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.